These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38353701)

  • 41. Design and testing of a highly conserved human rotavirus VP8* immunogenic peptide with potential for vaccine development.
    Mohanty E; Dehury B; Satapathy AK; Dwibedi B
    J Biotechnol; 2018 Sep; 281():48-60. PubMed ID: 29886031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lactobacilli and Bifidobacteria enhance mucosal B cell responses and differentially modulate systemic antibody responses to an oral human rotavirus vaccine in a neonatal gnotobiotic pig disease model.
    Kandasamy S; Chattha KS; Vlasova AN; Rajashekara G; Saif LJ
    Gut Microbes; 2014; 5(5):639-51. PubMed ID: 25483333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety, Immunogenicity, and Mechanism of a Rotavirus mRNA-LNP Vaccine in Mice.
    Lu C; Li Y; Chen R; Hu X; Leng Q; Song X; Lin X; Ye J; Wang J; Li J; Yao L; Tang X; Kuang X; Zhang G; Sun M; Zhou Y; Li H
    Viruses; 2024 Jan; 16(2):. PubMed ID: 38399987
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles.
    Crawford SE; Estes MK; Ciarlet M; Barone C; O'Neal CM; Cohen J; Conner ME
    J Virol; 1999 Jun; 73(6):4813-22. PubMed ID: 10233942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Maternal immunization of pregnant cattle with recombinant VP8* protein of bovine rotavirus elicits neutralizing antibodies to multiple serotypes. Colostral neutralizing antibody by rotavirus VP8*.
    Yoo D; Lee J; Harland R; Gibbons E; Elazhary Y; Babiuk LA
    Adv Exp Med Biol; 1997; 412():405-11. PubMed ID: 9192047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The VP5 domain of VP4 can mediate attachment of rotaviruses to cells.
    Zárate S; Espinosa R; Romero P; Méndez E; Arias CF; López S
    J Virol; 2000 Jan; 74(2):593-9. PubMed ID: 10623720
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The distinct impact of maternal antibodies on the immunogenicity of live and recombinant rotavirus vaccines.
    Yang H; Luo G; Zeng Y; Li Y; Yu S; Zhao B; An R; Zhang S; Wang Y; Li T; Ge S; Xia N
    Vaccine; 2019 Jul; 37(30):4061-4067. PubMed ID: 31182323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recombinant Subunit Rotavirus Trivalent Vaccine Candidate: Physicochemical Comparisons and Stability Evaluations of Three Protein Antigens.
    Agarwal S; Hickey JM; Sahni N; Toth RT; Robertson GA; Sitrin R; Cryz S; Joshi SB; Volkin DB
    J Pharm Sci; 2020 Jan; 109(1):380-393. PubMed ID: 31400347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantification of trivalent non-replicating rotavirus vaccine antigens in the presence of aluminum adjuvant.
    McAdams D; Lakatos K; Estrada M; Chen D; Plikaytis B; Sitrin R; White JA
    J Immunol Methods; 2021 Jul; 494():113056. PubMed ID: 33857473
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A dual chicken IgY against rotavirus and norovirus.
    Dai YC; Zhang XF; Tan M; Huang P; Lei W; Fang H; Zhong W; Jiang X
    Antiviral Res; 2013 Mar; 97(3):293-300. PubMed ID: 23267830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.
    Lappalainen S; Pastor AR; Tamminen K; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
    Hum Vaccin Immunother; 2014; 10(7):2039-47. PubMed ID: 25424814
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
    Choi AH; Basu M; Rae MN; McNeal MM; Ward RL
    Virology; 1998 Oct; 250(1):230-40. PubMed ID: 9770437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prenatal vitamin A deficiency impairs adaptive immune responses to pentavalent rotavirus vaccine (RotaTeq®) in a neonatal gnotobiotic pig model.
    Kandasamy S; Chattha KS; Vlasova AN; Saif LJ
    Vaccine; 2014 Feb; 32(7):816-24. PubMed ID: 24380684
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relative roles of GM1 ganglioside, N-acylneuraminic acids, and α2β1 integrin in mediating rotavirus infection.
    Fleming FE; Böhm R; Dang VT; Holloway G; Haselhorst T; Madge PD; Deveryshetty J; Yu X; Blanchard H; von Itzstein M; Coulson BS
    J Virol; 2014 Apr; 88(8):4558-71. PubMed ID: 24501414
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dual Recognition of Sialic Acid and αGal Epitopes by the VP8* Domains of the Bovine Rotavirus G6P[5] WC3 and of Its Mono-reassortant G4P[5] RotaTeq Vaccine Strains.
    Alfajaro MM; Kim JY; Barbé L; Cho EH; Park JG; Soliman M; Baek YB; Kang MI; Kim SH; Kim GJ; Park SI; Pendu JL; Cho KO
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31243129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Magnitude of serum and intestinal antibody responses induced by sequential replicating and nonreplicating rotavirus vaccines in gnotobiotic pigs and correlation with protection.
    Azevedo MS; Yuan L; Iosef C; Chang KO; Kim Y; Nguyen TV; Saif LJ
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):12-20. PubMed ID: 14715539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein.
    Gil MT; de Souza CO; Asensi M; Buesa J
    Viral Immunol; 2000; 13(2):187-200. PubMed ID: 10892999
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses.
    Jin Q; Ward RL; Knowlton DR; Gabbay YB; Linhares AC; Rappaport R; Woods PA; Glass RI; Gentsch JR
    Arch Virol; 1996; 141(11):2057-76. PubMed ID: 8973523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural Basis of Glycan Recognition in Globally Predominant Human P[8] Rotavirus.
    Sun X; Dang L; Li D; Qi J; Wang M; Chai W; Zhang Q; Wang H; Bai R; Tan M; Duan Z
    Virol Sin; 2020 Apr; 35(2):156-170. PubMed ID: 31620994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High titers of circulating maternal antibodies suppress effector and memory B-cell responses induced by an attenuated rotavirus priming and rotavirus-like particle-immunostimulating complex boosting vaccine regimen.
    Nguyen TV; Yuan L; Azevedo MS; Jeong KI; Gonzalez AM; Iosef C; Lovgren-Bengtsson K; Morein B; Lewis P; Saif LJ
    Clin Vaccine Immunol; 2006 Apr; 13(4):475-85. PubMed ID: 16603615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.